Could a cheap arthritis drug cut stroke survivors' heart risks?
NCT ID NCT06587737
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tests whether a low-dose anti-inflammatory drug called colchicine can help people who have had a brain hemorrhage (a type of stroke) recover better and avoid future heart attacks or strokes. About 1,125 adults with signs of artery disease will take either colchicine or a placebo daily for several years. The goal is to see if the drug reduces disability and major heart-related events without causing dangerous side effects like more bleeding.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COLCHICINE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Spinal zaps could reboot breathing after brain injury
- Can brain scans reveal hidden language struggles after stroke?
- Can lifestyle choices after a stroke extend life and prevent a second one?
- A tablet test aims to catch hidden attention and memory problems after stroke
- Could a decades-old arthritis drug protect dialysis patients' hearts and veins?
- Can a gentle ear zap supercharge stroke rehab at home?